Literature DB >> 25771414

Nondosimetric risk factors for radiation-induced lung toxicity.

Feng-Ming Spring Kong1, Shulian Wang2.   

Abstract

The decision to administer a radical course of radiotherapy (RT) is largely influenced by the dose-volume metrics of the treatment plan, but what are the patient-related and other factors that may independently increase the risk of radiation lung toxicity? Poor pulmonary function has been regarded as a risk factor and a relative contraindication for patients undergoing radical RT, but recent evidence suggests that patients with poor spirometry results may tolerate conventional or high-dose RT as well as, if not better than, patients with normal function. However, caution may need to be exercised in patients with underlying interstitial pulmonary fibrosis. Furthermore, there is emerging evidence of molecular markers of increased risk of toxicity. This review discusses patient-related risk factors other than dosimetry for radiation lung toxicity.
Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25771414      PMCID: PMC4400801          DOI: 10.1016/j.semradonc.2014.12.003

Source DB:  PubMed          Journal:  Semin Radiat Oncol        ISSN: 1053-4296            Impact factor:   5.934


  99 in total

1.  A single-nucleotide polymorphism in the methylene tetrahydrofolate reductase (MTHFR) gene is associated with risk of radiation pneumonitis in lung cancer patients treated with thoracic radiation therapy.

Authors:  Raymond H Mak; Brian M Alexander; Kofi Asomaning; Rebecca S Heist; Chen-yu Liu; Li Su; Rihong Zhai; Marek Ancukiewicz; Brian Napolitano; Andrzej Niemierko; Henning Willers; Noah C Choi; David C Christiani
Journal:  Cancer       Date:  2011-12-05       Impact factor: 6.860

2.  Changes in pulmonary function after three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, or proton beam therapy for non-small-cell lung cancer.

Authors:  Jose L Lopez Guerra; Daniel R Gomez; Yan Zhuang; Lawrence B Levy; George Eapen; Hongmei Liu; Radhe Mohan; Ritsuko Komaki; James D Cox; Zhongxing Liao
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-03-13       Impact factor: 7.038

Review 3.  Prediction of radiation pneumonitis in lung cancer patients: a systematic review.

Authors:  Xiao-Jing Zhang; Jian-Guo Sun; Jie Sun; Hua Ming; Xin-Xin Wang; Lei Wu; Zheng-Tang Chen
Journal:  J Cancer Res Clin Oncol       Date:  2012-07-29       Impact factor: 4.553

4.  Prescribing radiation dose to lung cancer patients based on personalized toxicity estimates.

Authors:  Yevgeniy Vinogradskiy; Susan L Tucker; Jaques B Bluett; Cody A Wages; Zhongxing Liao; Mary K Martel
Journal:  J Thorac Oncol       Date:  2012-11       Impact factor: 15.609

5.  A study of ethnic differences in TGFβ1 gene polymorphisms and effects on the risk of radiation pneumonitis in non-small-cell lung cancer.

Authors:  Xiaomin Niu; Hongxuan Li; Zhiwei Chen; Yun Liu; Mengyuan Kan; Daizhan Zhou; Ziming Li; Xiangyun Ye; Shengping Shen; Changxing Lv; Shun Lu
Journal:  J Thorac Oncol       Date:  2012-11       Impact factor: 15.609

6.  Combining physical and biologic parameters to predict radiation-induced lung toxicity in patients with non-small-cell lung cancer treated with definitive radiation therapy.

Authors:  Matthew H Stenmark; Xu-Wei Cai; Kerby Shedden; James A Hayman; Shuanghu Yuan; Timothy Ritter; Randall K Ten Haken; Theodore S Lawrence; Feng-Ming Spring Kong
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-10-01       Impact factor: 7.038

7.  Incorporating single-nucleotide polymorphisms into the Lyman model to improve prediction of radiation pneumonitis.

Authors:  Susan L Tucker; Minghuan Li; Ting Xu; Daniel Gomez; Xianglin Yuan; Jinming Yu; Zhensheng Liu; Ming Yin; Xiaoxiang Guan; Li-E Wang; Qingyi Wei; Radhe Mohan; Yevgeniy Vinogradskiy; Mary Martel; Zhongxing Liao
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-04-27       Impact factor: 7.038

8.  Predicting radiation pneumonitis after stereotactic ablative radiation therapy in patients previously treated with conventional thoracic radiation therapy.

Authors:  Hui Liu; Xu Zhang; Yevgeniy Y Vinogradskiy; Stephen G Swisher; Ritsuko Komaki; Joe Y Chang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-04-27       Impact factor: 7.038

9.  Functional and biologic metrics for predicting radiation pneumonitis in locally advanced non-small cell lung cancer patients treated with chemoradiotherapy.

Authors:  Dongqing Wang; Jingyu Zhu; Jinbo Sun; Baosheng Li; Zhongtang Wang; Ling Wei; Yong Yin; Hongfu Sun; Zheng Fu; Xingguo Zhang; Zongwei Huo
Journal:  Clin Transl Oncol       Date:  2012-07-20       Impact factor: 3.405

Review 10.  A literature-based meta-analysis of clinical risk factors for development of radiation induced pneumonitis.

Authors:  Ivan R Vogelius; Søren M Bentzen
Journal:  Acta Oncol       Date:  2012-09-05       Impact factor: 4.089

View more
  45 in total

1.  Genetic variants in the ITGB6 gene is associated with the risk of radiation pneumonitis in lung cancer patients treated with thoracic radiation therapy.

Authors:  Minxiao Yi; Yang Tang; Bo Liu; Qianxia Li; Xiao Zhou; Shiying Yu; Shengling Fu; Yixin Cai; Xianglin Yuan
Journal:  Tumour Biol       Date:  2015-10-08

2.  Unraveling biophysical interactions of radiation pneumonitis in non-small-cell lung cancer via Bayesian network analysis.

Authors:  Yi Luo; Issam El Naqa; Daniel L McShan; Dipankar Ray; Ines Lohse; Martha M Matuszak; Dawn Owen; Shruti Jolly; Theodore S Lawrence; Feng-Ming Spring Kong; Randall K Ten Haken
Journal:  Radiother Oncol       Date:  2017-02-22       Impact factor: 6.280

3.  Relationship between dose-volume parameters and pulmonary complications after neoadjuvant chemoradiotherapy followed by surgery for lung cancer.

Authors:  Shigeo Takahashi; Tetsuhiko Go; Yoshitaka Kasai; Hiroyasu Yokomise; Toru Shibata
Journal:  Strahlenther Onkol       Date:  2016-07-14       Impact factor: 3.621

4.  Radiation-induced lung toxicity in non-small-cell lung cancer: Understanding the interactions of clinical factors and cytokines with the dose-toxicity relationship.

Authors:  Peter G Hawkins; Philip S Boonstra; Stephen T Hobson; Jason W D Hearn; James A Hayman; Randall K Ten Haken; Martha M Matuszak; Paul Stanton; Gregory P Kalemkerian; Nithya Ramnath; Theodore S Lawrence; Matthew J Schipper; Feng-Ming Spring Kong; Shruti Jolly
Journal:  Radiother Oncol       Date:  2017-09-23       Impact factor: 6.280

5.  Investigation of the evolution of radiation-induced lung damage using serial CT imaging and pulmonary function tests.

Authors:  Catarina Veiga; Edward Chandy; Joseph Jacob; Natalie Yip; Adam Szmul; David Landau; Jamie R McClelland
Journal:  Radiother Oncol       Date:  2020-03-30       Impact factor: 6.280

6.  Image-based lung functional radiotherapy planning for non-small cell lung cancer.

Authors:  Faegheh S Mounessi; Jörg Eckardt; Arne Holstein; Santiago Ewig; Stefan Könemann
Journal:  Strahlenther Onkol       Date:  2019-10-02       Impact factor: 3.621

7.  Ultra-high dose rate effect on circulating immune cells: A potential mechanism for FLASH effect?

Authors:  Jian-Yue Jin; Anxin Gu; Weili Wang; Nancy L Oleinick; Mitchell Machtay; Feng-Ming Spring Kong
Journal:  Radiother Oncol       Date:  2020-05-06       Impact factor: 6.280

8.  Loss of Nrf2 promotes alveolar type 2 cell loss in irradiated, fibrotic lung.

Authors:  Geri Traver; Stacey Mont; David Gius; William E Lawson; George X Ding; Konjeti R Sekhar; Michael L Freeman
Journal:  Free Radic Biol Med       Date:  2017-09-01       Impact factor: 7.376

Review 9.  Blood-based biomarkers for precision medicine in lung cancer: precision radiation therapy.

Authors:  Dirk De Ruysscher; Jianyue Jin; Tim Lautenschlaeger; Jin-Xiong She; Zhongxing Liao; Feng-Ming Spring Kong
Journal:  Transl Lung Cancer Res       Date:  2017-12

10.  Does the presence of emphysema increase the risk of radiation pneumonitis in lung cancer patients?

Authors:  G Kasymjanova; R T Jagoe; C Pepe; L Sakr; V Cohen; D Small; T M Muanza; J S Agulnik
Journal:  Curr Oncol       Date:  2018-12-01       Impact factor: 3.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.